Get the SPI Wire

IGC Pharma, Inc.

NYSE:IGC
Annual Meeting

of Shareholders

MEETING DATE

12/02/2026
DEF 14A FILED
10/22/2026
PUBLISHED
10/22/2026 12:32 am
TIME TO PUBLISH
10/24/2026
METHODOLOGY
approve
EXCHANGE NYSE:IGC · CUSIP 45408X100 · CLASS common stock · CIK 0001326205

RECONCILED · MIXED

Reconciled against the company’s Form 8-K Item 5.07 filed 2026-06-15.

7
FOR
0
AGAINST
0
WITHHOLD
7
BALLOT ITEMS

ITEM-BY-ITEM RECOMMENDATIONS

1
To elect Ms. Claudia Grimaldi to the Company’s Board of Directors to serve as a Class A director until the 2029 Annual Meeting of Stockholders, until such director’s successor shall be duly elected and qualified, or until such director’s earlier death, resignation, or removal from office
board
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

The Board of Directors has nominated Ms. Claudia Grimaldi to serve as a Class A director.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
2
To approve an amendment to Section 4.1 of the Company’s 2018 Omnibus Incentive Plan to change the annual share reserve adjustment date from April 1 to January 1 of each year, effective January 1, 2027
compensation
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

The filing states the amendment aligns the annual share reserve adjustment with the Company’s fiscal year.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
3
To approve an amendment to Section 4.1 of the Company’s 2018 Omnibus Incentive Plan to increase the annual share reserve percentage from fifteen percent (15%) to twenty percent (20%), effective January 1, 2027
compensation
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

The filing states the amendment maintains an adequate reserve for equity awards.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
4
To approve the grant of 5,000,000 shares of common stock, governed by the Company’s 2018 Omnibus Incentive Plan, to be granted from time to time to the Company’s current and new employees, officers, advisors, directors, and consultants by the Board of Directors, pursuant to certain metrics including performance, vesting, and incentive as set by the Board of Directors and or the CEO
compensation
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

The filing states the grant is intended to align interests and retain personnel.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
5
To approve, by a non-binding advisory vote, the compensation of the Company’s named executive officers as disclosed pursuant to the SEC’s compensation disclosure rules (which disclosure includes the compensation tables, and the narrative disclosures that accompany the compensation tables) (the “Say-on-Pay Proposal”)
compensation
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

The filing states the executive compensation program emphasizes long-term equity awards.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
6
To ratify the appointment of Manohar Chowdhry & Associates, as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026
auditor
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

The Audit Committee received the auditor independence letter and discussed independence with Manohar Chowdhry & Associates.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
7
To act upon such other matters as may properly come before the Annual Meeting, including any proposal to adjourn or postpone the Annual Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies (the “Adjournment Proposal”)
other
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

The filing states adjournment could provide additional time to solicit additional proxies.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.

Ledger

41671e36d6a354924395ccd6e24fec0910e02bc16d632e7893b7a54143c04049

Search company, ticker, executive, director or issue

    The SPI Wire · Proxy Intelligence

    Get every ballot call, before the vote.

    FOR, AGAINST or WITHHOLD on each covered ballot item — published within 48 hours of the definitive proxy filing. Follow the companies you own, or take the full feed.




    Pick the companies you own — you’ll only hear from us on their ballots.

    The SPI Wire covers proxy ballots only — it has nothing to do with Signal Research investigations. Research and analysis for informational purposes; not legal, investment, or voting advice. Unsubscribe anytime.

    Submit Information








      Join Monitoring List




        Receive Research Updates